Jordan Elm to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Jordan Elm has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.497
-
Flexible analytical methods for adding a treatment arm mid-study to an ongoing clinical trial. J Biopharm Stat. 2012; 22(4):758-72.
Score: 0.388
-
Recombinant factor VIIa for hemorrhagic stroke treatment at earliest possible time (FASTEST): Protocol for a phase III, double-blind, randomized, placebo-controlled trial. Int J Stroke. 2022 08; 17(7):806-809.
Score: 0.047
-
The multiarm optimization of stroke thrombolysis phase 3 acute stroke randomized clinical trial: Rationale and methods. Int J Stroke. 2021 10; 16(7):873-880.
Score: 0.045
-
Optimizing the ongoing search for new treatments for Parkinson disease: using futility designs. Neurology. 2006 Mar 14; 66(5):628-33.
Score: 0.016